ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,357, issued on May 27, was assigned to ANTENGENE DISCOVERY Ltd. (Shanghai).
"PRMT5 inhibiting compounds and uses thereof" was invented by Ming Zhang (Shanghai), Ya Kong (Shanghai), Lulu Jiang (Shanghai), Bin Jiang (Shanghai), Guoqiang Dai (Shanghai), Yulong He (Shanghai), Bing Hou (Shanghai), Bo Shan (Shanghai) and Jay Mei (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides novel PRMT5 and/or MTA-cooperative PRMT5 inhibiting compounds, or pharmaceutically acceptable salts thereof. The present application also provides pharmaceutical compositions comprising one or more of the compounds, or pharmaceutically accept...